1 – 15 of 36
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort
2024) In Journal of Neurology(
- Contribution to journal › Article
-
Mark
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings
(
- Contribution to journal › Article
-
Mark
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure
2024) In Annals of Clinical and Translational Neurology(
- Contribution to journal › Article
-
Mark
Investigating reliable amyloid accumulation in Centiloids : Results from the AMYPAD Prognostic and Natural History Study
(
- Contribution to journal › Article
-
Mark
Amyloid-PET imaging predicts functional decline in clinically normal individuals
(
- Contribution to journal › Article
-
Mark
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
2023) In European Journal of Nuclear Medicine and Molecular Imaging(
- Contribution to journal › Article
-
Mark
Recruitment of pre-dementia participants : main enrollment barriers in a longitudinal amyloid-PET study
(
- Contribution to journal › Article
-
Mark
European consensus for the diagnosis of MCI and mild dementia : Preparatory phase
(
- Contribution to journal › Article
-
Mark
Dementia prevention in memory clinics : recommendations from the European task force for brain health services
(
- Contribution to journal › Scientific review
- 2022
-
Mark
The probabilistic model of Alzheimer disease : the amyloid hypothesis revised
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Management of Alzheimer's disease takes a leap forward
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
(
- Contribution to journal › Scientific review
-
Mark
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers : methodological update
(
- Contribution to journal › Article